Market Overview

Wedbush Previews NVIDIA's Q4 Results, Expects 'Solid' Beat


Betsy Van Hees of Wedbush on Monday previewed NVIDIA Corporation's (NASDAQ: NVDA) upcoming fourth-quarter report which is scheduled to be released on Wednesday.

"We expect a solid beat primarily driven by strong PC gaming demand, data center strength, and market share gains," Van Hees wrote. The analyst expects the company will report a GAAP earnings per share of $0.30 on revenue of $1.22 billion after previously projecting an earnings per share of $0.28 on revenue of $1.20 billion.

Looking forward to the first quarter, Van Hees expects NVIDIA will see typical seasonality in its business, especially PC gaming while the company continues executing on keeping its costs in check. The analyst is guiding the company to earn $0.24 in the coming quarter on revenue of $1.15 billion.

Van Hees concludes by stating as shares continue trading near 52-week highs, there likely won't be much reaction off a beat and in-line guide and that the company's upcoming Analyst Day on March 17 won't be a catalyst. In fact, the analyst suggests that shares will trade in a narrow range until mid-June when its patent infringement claim against Samsung and Qualcomm will be heard by the International Trade Commission.

Shares are Outperform rated with a $25 price target.

Latest Ratings for NVDA

Nov 2019MaintainsBuy
Nov 2019MaintainsOutperform
Nov 2019MaintainsHold

View More Analyst Ratings for NVDA
View the Latest Analyst Ratings

Posted-In: Betsy Van Hees International Trade Commission NVIDIA PC PC Gaming QualcommAnalyst Color Analyst Ratings


Related Articles (NVDA)

View Comments and Join the Discussion!

Latest Ratings

KEMB. Riley FBRDowngrades27.2
ROKGabelli & Co.Downgrades
SSRMB. Riley FBRUpgrades23.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Citi On The Impact Of Biosimilars And Losing $360 Billion In Revenues

The Technician's Take On Petrobras In 1 Picture